down arrow

Oscar Health, Inc.

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: US6877931096
USD
14.80
-0.59 (-3.83%)

Dec 18

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

14.6215.87

52 Week

11.2023.74
Valuation
Technical
Day's Volume

CASH

9.65 M

Shareholding (Mar 2025)

FII

9.62%

Held by 125 FIIs

DII

34.17%

Held by 62 DIIs

Promoter

17.44%

How big is Oscar Health, Inc.?

22-Jun-2025

As of Jun 18, Oscar Health, Inc. has a market capitalization of $4.11 billion and reported net sales of $0.00 million with a net profit of $124.15 million over the latest four quarters. The company's shareholder's funds were $1.01 billion, and total assets amounted to $4.55 billion as of Dec 24.

Market Cap: As of Jun 18, Oscar Health, Inc. has a market capitalization of 4,107.92 million, classifying it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Oscar Health, Inc. reported net sales of 0.00 million and a net profit of 124.15 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company's shareholder's funds amounted to 1,013.59 million, while total assets were reported at 4,548.96 million.

Read More

What does Oscar Health, Inc. do?

22-Jun-2025

Oscar Health, Inc. is a small-cap company in the Healthcare Services industry, with a market cap of approximately $4.1 billion and a net profit of $276 million as of March 2025. Key metrics include a P/E ratio of 32.00 and a return on equity of 9.31%.

Overview:<BR>Oscar Health, Inc. operates in the Healthcare Services industry and is classified as a small-cap company.<BR><BR>Financial Snapshot:<BR>- Net Profit: 276 Million (Quarterly Results - Mar 2025)<BR>- Market Cap: USD 4,107.92 Million (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 32.00<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -2.02<BR>- Return on Equity: 9.31%<BR>- Price to Book: 3.08<BR><BR>Contact Details:<BR>No Company Details Available.

Read More

Is Oscar Health, Inc. overvalued or undervalued?

20-Sep-2025

As of August 6, 2025, Oscar Health, Inc. is considered overvalued with a risky valuation grade, reflected by its high P/E ratio of 32 and EV to EBITDA ratio of 40.04, despite impressive three-year growth, as it has underperformed the S&P 500 over the past year.

As of 6 August 2025, the valuation grade for Oscar Health, Inc. has moved from fair to risky, indicating a shift in perception regarding its financial health and market position. The company appears to be overvalued, particularly when considering its high P/E ratio of 32 and an EV to EBITDA ratio of 40.04, which are significantly above industry norms, as evidenced by peers such as Molina Healthcare, Inc. with a P/E of 8.42 and an EV to EBITDA of 20.30.<BR><BR>In addition, Oscar Health's PEG ratio of 0.10 suggests that its growth prospects may not justify its current valuation. The company has also underperformed compared to the S&P 500 over the past year, with a stock return of -15.44% versus the index's 17.14%, although it has shown impressive growth over the past three years with a return of 232.93% compared to the S&P 500's 70.41%. This mixed performance further reinforces the notion that Oscar Health is currently overvalued in the market.

Read More

Is Oscar Health, Inc. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, Oscar Health, Inc. is in a bullish trend with strong indicators, despite some caution from the KST and OBV, and has outperformed the S&P 500 with a year-to-date return of 66.0% compared to 14.18%.

As of 3 October 2025, the technical trend for Oscar Health, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both weekly and monthly timeframes, and Bollinger Bands are also bullish in the same periods. Daily moving averages confirm a bullish trend as well. However, the KST is mildly bearish on a monthly basis, and the OBV shows mild bearishness on both weekly and monthly timeframes, indicating some caution. <BR><BR>In terms of performance, Oscar Health has significantly outperformed the S&P 500 with a year-to-date return of 66.0% compared to the S&P 500's 14.18%, and an impressive 369.68% return over the past three years versus the S&P 500's 82.57%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

The company has declared negative results in Jan 70 after 9 consecutive negative quarters

  • OPERATING PROFIT(Q) Lowest at USD -230.48 MM
  • OPERATING PROFIT MARGIN(Q) Lowest at -8.05 %
  • PRE-TAX PROFIT(Q) Lowest at USD -233.54 MM
2

Risky - Negative Operating Profits

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

USD 5,250 Million (Small Cap)

stock-summary
P/E

32.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-2.79

stock-summary
Return on Equity

-13.87%

stock-summary
Price to Book

4.53

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-228 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-22.55%
0%
-22.55%
6 Months
-21.15%
0%
-21.15%
1 Year
10.61%
0%
10.61%
2 Years
92.71%
0%
92.71%
3 Years
543.48%
0%
543.48%
4 Years
79.18%
0%
79.18%
5 Years
0%
0%
0.0%

Oscar Health, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Oscar Health Hits Day High with 7% Surge, Outperforming Market

Oscar Health Hits Day High with 7% Surge, Outperforming Market

Oscar Health, Inc. saw a significant stock increase today, contrasting with the modest rise of the S&P 500. While the company has gained year-to-date, its longer-term performance shows challenges, including a decline over the past month and a negative one-year return. Oscar Health operates in the healthcare services sector.

Read More
Oscar Health Hits Day High with 8.68% Surge Amid Market Decline

Oscar Health Hits Day High with 8.68% Surge Amid Market Decline

Oscar Health, Inc. has seen a significant rise in its stock today, reaching an intraday high and contrasting with a decline in the S&P 500. Year-to-date, the company has outperformed the index, though it has faced challenges over the past year. Its market capitalization stands at USD 5,250 million.

Read More
Oscar Health, Inc. Hits New 52-Week High at $23.74

Oscar Health, Inc. Hits New 52-Week High at $23.74

Oscar Health, Inc. achieved a new 52-week high of USD 23.74 on October 7, 2025, reflecting a year-over-year performance of 9.56%. With a market capitalization of USD 5,250 million, the company has a P/E ratio of 32.00 and a price-to-book ratio of 4.53, indicating its valuation dynamics.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
74.45%
EBIT Growth (5y)
29.59%
EBIT to Interest (avg)
-0.20
Debt to EBITDA (avg)
11.31
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
5.35
Tax Ratio
13.28%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
1.86%
Valuation key factors
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
2.95
EV to EBIT
1243.68
EV to EBITDA
40.04
EV to Capital Employed
-0.92
EV to Sales
0.12
PEG Ratio
0.10
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
9.31%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 71 Schemes (38.78%)

Foreign Institutions

Held by 125 Foreign Institutions (9.62%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -505.86% vs 465.58% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.00",
          "val2": "7.60",
          "chgp": "-7.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.80",
          "val2": "6.00",
          "chgp": "-3.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-228.50",
          "val2": "56.30",
          "chgp": "-505.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-80.50%",
          "val2": "30.60%",
          "chgp": "-11.11%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 109.65% vs 55.61% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.10",
          "val2": "30.70",
          "chgp": "4.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "23.70",
          "val2": "24.60",
          "chgp": "-3.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "26.10",
          "val2": "-270.60",
          "chgp": "109.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.20%",
          "val2": "-40.20%",
          "chgp": "4.64%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
7.00
7.60
-7.89%
Interest
5.80
6.00
-3.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-228.50
56.30
-505.86%
Operating Profit Margin (Excl OI)
-80.50%
30.60%
-11.11%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -505.86% vs 465.58% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
32.10
30.70
4.56%
Interest
23.70
24.60
-3.66%
Exceptional Items
0.00
0.00
Consolidate Net Profit
26.10
-270.60
109.65%
Operating Profit Margin (Excl OI)
6.20%
-40.20%
4.64%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 109.65% vs 55.61% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Oscar Health, Inc. stock-summary
stock-summary
Oscar Health, Inc.
Healthcare Services
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."